Result 1 - 10 of total 10
The Chicago medical journal and examiner
2023 Volume 46, Issue 2, Page(s) 204–217
| Language | English |
|---|---|
| Publishing date | 2023-08-24 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
The Southern medical record
2022 Volume 14, Issue 2, Page(s) 57–60
| Language | English |
|---|---|
| Publishing date | 2022-08-26 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
Journal of psychological medicine and mental pathology (London, England : 1875)
2017 Volume 8, Issue Pt 2, Page(s) 264–275
| Language | English |
|---|---|
| Publishing date | 2017-09-14 |
| Publishing country | England |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
1888 Volume 7, Issue -, Page(s) 457
| Language | German |
|---|---|
| Document type | Article |
| ZDB-ID | 200969-9 |
| Database | Current Contents Medicine |
| Ui II Zs.30: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
1898 Volume 17, Issue -, Page(s) 202
| Language | German |
|---|---|
| Document type | Article |
| ZDB-ID | 200969-9 |
| Database | Current Contents Medicine |
| Ui II Zs.30: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
2020 Volume 69, Issue 1, Page(s) 1–11
Abstract: Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among persons living in the United States were last published in 2000 (American Thoracic Society. CDC targeted tuberculin testing and treatment of latent tuberculosis ... ...
| Abstract | Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among persons living in the United States were last published in 2000 (American Thoracic Society. CDC targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47). Since then, several new regimens have been evaluated in clinical trials. To update previous guidelines, the National Tuberculosis Controllers Association (NTCA) and CDC convened a committee to conduct a systematic literature review and make new recommendations for the most effective and least toxic regimens for treatment of LTBI among persons who live in the United States.The systematic literature review included clinical trials of regimens to treat LTBI. Quality of evidence (high, moderate, low, or very low) from clinical trial comparisons was appraised using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. In addition, a network meta-analysis evaluated regimens that had not been compared directly in clinical trials. The effectiveness outcome was tuberculosis disease; the toxicity outcome was hepatotoxicity. Strong GRADE recommendations required at least moderate evidence of effectiveness and that the desirable consequences outweighed the undesirable consequences in the majority of patients. Conditional GRADE recommendations were made when determination of whether desirable consequences outweighed undesirable consequences was uncertain (e.g., with low-quality evidence).These updated 2020 LTBI treatment guidelines include the NTCA- and CDC-recommended treatment regimens that comprise three preferred rifamycin-based regimens and two alternative monotherapy regimens with daily isoniazid. All recommended treatment regimens are intended for persons infected with Mycobacterium tuberculosis that is presumed to be susceptible to isoniazid or rifampin. These updated guidelines do not apply when evidence is available that the infecting M. tuberculosis strain is resistant to both isoniazid and rifampin; recommendations for treating contacts exposed to multidrug-resistant tuberculosis were published in 2019 (Nahid P, Mase SR Migliori GB, et al. Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline. Am J Respir Crit Care Med 2019;200:e93-e142). The three rifamycin-based preferred regimens are 3 months of once-weekly isoniazid plus rifapentine, 4 months of daily rifampin, or 3 months of daily isoniazid plus rifampin. Prescribing providers or pharmacists who are unfamiliar with rifampin and rifapentine might confuse the two drugs. They are not interchangeable, and caution should be taken to ensure that patients receive the correct medication for the intended regimen. Preference for these rifamycin-based regimens was made on the basis of effectiveness, safety, and high treatment completion rates. The two alternative treatment regimens are daily isoniazid for 6 or 9 months; isoniazid monotherapy is efficacious but has higher toxicity risk and lower treatment completion rates than shorter rifamycin-based regimens.In summary, short-course (3- to 4-month) rifamycin-based treatment regimens are preferred over longer-course (6-9 month) isoniazid monotherapy for treatment of LTBI. These updated guidelines can be used by clinicians, public health officials, policymakers, health care organizations, and other state and local stakeholders who might need to adapt them to fit individual clinical circumstances. |
|---|---|
| MeSH term(s) | Centers for Disease Control and Prevention, U.S. ; Humans ; Latent Tuberculosis/drug therapy ; Practice Guidelines as Topic ; Randomized Controlled Trials as Topic ; United States |
| Language | English |
| Publishing date | 2020-02-14 |
| Publishing country | United States |
| Document type | Journal Article ; Systematic Review |
| ZDB-ID | 1020048-4 |
| ISSN | 1545-8601 ; 1057-5987 |
| ISSN (online) | 1545-8601 |
| ISSN | 1057-5987 |
| DOI | 10.15585/mmwr.rr6901a1 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
| Zs.B 1827 -RR-: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
The Southern medical record
1898 Volume 28, Issue 12, Page(s) 750–756
| Language | English |
|---|---|
| Publishing date | 1898-12 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
The Southern medical record
1898 Volume 28, Issue 7, Page(s) 369–376
| Language | English |
|---|---|
| Publishing date | 1898-07 |
| Publishing country | United States |
| Document type | Journal Article |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
1912
| Author's details | by Philip Zenner |
|---|---|
| Language | English |
| Size | 2 p. l., iii-iv, 160 p. |
| Publisher | Stewart & Kidd company |
| Publishing place | Cincinnati |
| Document type | Book |
| Note | Advertising matter, pages 158-160. |
| Database | Catalogue of the US National Library of Medicine (NLM) |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.
a physician's message
1910
| Language | English |
|---|---|
| Size | viii, 126 p. |
| Publisher | Clarke |
| Publishing place | Cincinnati |
| Document type | Book |
| Database | Catalogue of the US National Library of Medicine (NLM) |
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.